Pharma & Biopharma

Illuminating antiretroviral accumulation in the brain using LC-MS and MALDI-MSI - the key to tackling HIV-associated neurocognitive disorder?

Tomasz Walski, Project Group Leader in the R&D department at Mabion S.A., tells us how he is keeping glycan analysis short and sweet.

How can analytical chemistry support the rise of organoids and organ-on-a-chip technologies?

2D-LC-MS brings important benefits to the fields of pharma, biopharma, omics, and natural product analysis.

Shane Tichy reveals the story behind the new InfinityLab LC/MSD iQ System.

Andrew Lynn, CEO of Fluidic Analytics, shares his expertise on the use of microfluidics to study protein interactions.

A united front against antimicrobial resistance requires rapid diagnostics.

A triumph of biomedical engineering, organ-on-a-chip technology has given researchers an exciting new tool to explore biology.

Forty years ago, it was theorized that chirality had a color composition that could be measured... and finally the theory has been proven.

Ready or not, automation is coming soon to analytical labs everywhere. Here’s why we should rejoice – rather than resist – the rise of the machines.